Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02523118 · ClinicalTrials.gov registry record
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
A clinical trial of Eosinophilic Esophagitis and Eosinophilic Gastroenteritis, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 1,350
- Enrollment target
- 19
- Study locations
NCT02523118 is a study of Eosinophilic Esophagitis and Eosinophilic Gastroenteritis that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 1,350 participants, above the 833-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (62% higher). The trial reports 19 study locations across 16 states.
The verdict
NCT02523118, a study of Eosinophilic Esophagitis and Eosinophilic Gastroenteritis, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 1,350 participants
- Enrollment target
- 19
- Study locations
Study Summary
The purpose of this observational study is to find the best measures to define how well a person with eosinophilic disorder is doing. People with EoE, EoG, EoN and EoC normally undergo endoscopy and/or colonoscopy where cells are collected for microscopic analysis. Treatments are then decided based on how the cells look. We are aiming to compare different tissue components such as inflammatory cell types with clinical symptoms. We want to see if scores on standard questionnaires can give us an idea how well the person is doing.
Conditions Studied
Study Locations (19)
Colorado
- University of Colorado Denver - Aurora
- Children's Hospital Colorado - Denver
Illinois
- Northwestern University - Chicago
- Ann and Robert H. Lurie Children's Hospital of Chicago - Chicago
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- University of Pennsylvania - Philadelphia
Arizona
- Mayo Clinic Hospital - Phoenix
Arkansas
- Arkansas Children's Research Institute - Rogers
California
- Rady Children's Hospital - San Diego
Indiana
- Riley Children's Hospital - Indianapolis
Maryland
- National Institutes of Health (NIH) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,350 participants |
| Start Date | 2015-07-17 |
| Est. Completion | 2051-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02523118
The ClinicalTrials.gov registry entry for NCT02523118 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,350 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 833-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (62% higher). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 0 interventions.
NCT02523118 reports 19 study locations spanning 16 distinct geographic areas - top geographies include Colorado, Illinois, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02523118 about?
NCT02523118 is a clinical study titled "OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages". The purpose of this observational study is to find the best measures to define how well a person with eosinophilic disorder is doing. People with EoE, EoG, EoN and EoC normally undergo endoscopy and/or colonoscopy where cells are collected for microscopic analysis. Treatments are then decided based ...
What is the current status of trial NCT02523118?
This trial is currently recruiting. The enrollment target is 1,350 participants. The study started on 2015-07-17. Estimated completion is 2051-01-01.
What conditions does trial NCT02523118 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, Eosinophilic Gastritis, Eosinophilic Colitis, Eosinophilic Gastrointestinal Disorders (EGIDs).
Who is sponsoring clinical trial NCT02523118?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02523118 being conducted?
This trial has 19 study locations across Arizona, Arkansas, California, Colorado, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characteristics and Inflammatory Markers in Children with Eosinophilic Esophagitis (EoE)
RECRUITING
-
Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
A Registry for the Food Allergy Community
RECRUITING
-
Patient-Centered Decision Support for Eosinophilic Esophagitis
RECRUITING · NA
-
Eosinophilic Gastrointestinal Disorders Registry
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.